CapsoVision (CV) EBITDA (2024 - 2026)
CapsoVision (CV) posted EBITDA of -$7.5 million for Q4 2025, up 6.92% sequentially from -$8.0 million in Q3 2025, and down 61.07% YoY from -$19.2 million in Q4 2024.
CapsoVision (CV) EBITDA (2024 - 2026) Analysis & Trends
CapsoVision has reported EBITDA for 2 years, with the latest figure at -$7.5 million in Q4 2025.
- Quarterly EBITDA fell 61.07% year-over-year to -$7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$24.8 million (changed N/A YoY) and the FY2025 annual result came in at -$25.5 million, down 28.11% from the prior year.
- EBITDA improved to -$7.5 million in Q4 2025 per CV's latest filing, from -$8.0 million in the prior quarter.
- Over five years, EBITDA peaked at -$4.6 million in Q4 2024 and troughed at -$8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 285.80 Mn |
| 10 | CapsoVision | 295.63 Mn | 286.55 Mn | 1.87 Mn | -7.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.58 Mn |
| Dec 31, 2025 | -7.46 Mn |
| Sep 30, 2025 | -8.02 Mn |
| Jun 30, 2025 | -4.65 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -5.80 Mn |
| Jun 30, 2024 | -5.27 Mn |